Log in

NYSE:HUMHumana Stock Price, Forecast & News

$415.77
-3.99 (-0.95 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$414.76
Now: $415.77
$425.46
50-Day Range
$374.64
MA: $392.97
$419.76
52-Week Range
$208.25
Now: $415.77
$425.46
Volume565,496 shs
Average Volume1.20 million shs
Market Capitalization$55.00 billion
P/E Ratio15.81
Dividend Yield0.60%
Beta0.86
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2018, the company had approximately 17 million members in medical benefit plans, as well as approximately 6 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Read More
Humana logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.88 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.89 billion
Cash Flow$22.40 per share
Book Value$90.90 per share

Profitability

Net Income$2.71 billion

Miscellaneous

Employees46,000
Market Cap$55.00 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$415.77
-3.99 (-0.95 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Humana (NYSE:HUM) Frequently Asked Questions

How has Humana's stock been impacted by COVID-19 (Coronavirus)?

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HUM stock has increased by 26.7% and is now trading at $415.77.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Humana?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Humana
.

When is Humana's next earnings date?

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Humana
.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) released its quarterly earnings results on Wednesday, August, 5th. The insurance provider reported $12.56 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $10.34 by $2.22. The insurance provider earned $19.08 billion during the quarter, compared to analyst estimates of $18.66 billion. Humana had a return on equity of 26.70% and a net margin of 4.96%. The company's revenue was up 17.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.05 EPS.
View Humana's earnings history
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, April 23rd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.625 per share on Friday, July 31st. This represents a $2.50 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Monday, June 29th.
View Humana's dividend history
.

What guidance has Humana issued on next quarter's earnings?

Humana updated its FY20 earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of $18.25-18.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $18.71.

What price target have analysts set for HUM?

21 analysts have issued 12-month price objectives for Humana's shares. Their forecasts range from $290.00 to $510.00. On average, they expect Humana's stock price to reach $424.33 in the next twelve months. This suggests a possible upside of 2.1% from the stock's current price.
View analysts' price targets for Humana
.

Has Humana been receiving favorable news coverage?

Press coverage about HUM stock has been trending very positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a news sentiment score of 3.3 on InfoTrie's scale. They also assigned news stories about the insurance provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about Humana
.

Are investors shorting Humana?

Humana saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 2,170,000 shares, an increase of 12.4% from the January 15th total of 1,930,000 shares. Based on an average daily volume of 985,400 shares, the days-to-cover ratio is presently 2.2 days. Currently, 1.7% of the company's shares are short sold.
View Humana's Short Interest
.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), Alibaba Group (BABA), NVIDIA (NVDA), Visa (V), Boeing (BA), Walt Disney (DIS), Mastercard (MA), salesforce.com (CRM), JPMorgan Chase & Co. (JPM) and CVS Health (CVS).

Who are Humana's key executives?

Humana's management team includes the following people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by a variety of retail and institutional investors. Top institutional investors include Newport Trust Co (1.15%), Jennison Associates LLC (0.75%), Diamond Hill Capital Management Inc. (0.53%), Sumitomo Mitsui Trust Holdings Inc. (0.52%), Swiss National Bank (0.46%) and New York State Common Retirement Fund (0.23%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval.
View institutional ownership trends for Humana
.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Jennison Associates LLC, Unigestion Holding SA, Toronto Dominion Bank, Russell Investments Group Ltd., Scout Investments Inc., New York State Common Retirement Fund, and First Trust Advisors LP. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley, and Timothy S Huval.
View insider buying and selling activity for Humana
.

Which institutional investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including Strs Ohio, MERIAN GLOBAL INVESTORS UK Ltd, Railway Pension Investments Ltd, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Todd Asset Management LLC, Frontier Capital Management Co. LLC, Robeco Institutional Asset Management B.V., and Teacher Retirement System of Texas.
View insider buying and selling activity for Humana
.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $415.77.

How big of a company is Humana?

Humana has a market capitalization of $55.00 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

What is Humana's official website?

The official website for Humana is www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.